SPY328.79+2.27 0.70%
DIA266.72+2.37 0.90%
IXIC10,902.80+157.52 1.47%
News
ADPT
--
0.00%
--
Is Adaptive Biotechnologies a Buy?
There's nothing like a viral pandemic to remind investors how important it is to understand the human immune system. Shares of Adaptive Biotechnologies (NASDAQ: ADPT) soared when the biotech took steps to address the coronavirus pandemic and partnered with Am
Motley Fool · 4d ago
Adaptive Biotechnologies Launches National Clinical Trial to Develop Novel T-Cell Based Diagnostic for Lyme Disease
Current tests are highly inaccurate, resulting in lengthy diagnostic journeySEATTLE, July 28, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corp. (Nasdaq: ADPT) announced today the launch of ImmuneSense Lyme™, a research study to inform the development of
GlobeNewswire · 6d ago
Better Buy: Amgen vs. Gilead Sciences
MotleyFool.com · 07/21 11:01
Adaptive Biotechnologies (ADPT) Upgraded to Buy: What Does It Mean for the Stock?
Adaptive Biotechnologies (ADPT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Zacks · 07/16 16:00
Adaptive Biotechnologies Announces Pricing of Public Offering of Common Stock
SEATTLE, July 15, 2020 -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive.
GlobeNewswire · 07/15 23:47
Adaptive Biotechnologies Announces Proposed Public Offering of Common Stock
SEATTLE, July 14, 2020 -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive.
GlobeNewswire · 07/14 20:44
Here's Why Adaptive Biotechnologies Soared 61.7% in the First Half of 2020
Motley Fool · 07/09 21:29
Adaptive Biotechnologies to Report Second Quarter Financial Results on August 10, 2020
GlobeNewswire · 07/09 13:05
2 Stocks That Could Make You Rich
MotleyFool.com · 06/25 11:08
Hedge Funds Never Been Less Bullish On Adaptive Biotechnologies Corporation (ADPT)
Insider Monkey · 06/23 16:54
Is Amgen Stock a Buy?
MotleyFool.com · 06/18 13:31
How Adaptive Biotechnologies (ADPT) Stock Stands Out in a Strong Industry
Zacks · 06/17 13:56
Microsoft (MSFT) and Adaptive Roll Out ImmuneCODE Database
Zacks · 06/15 15:27
ArcherDx Begins U.S. IPO Rollout
Seeking Alpha - Article · 06/11 19:03
Adaptive Biotechnologies and Microsoft launch groundbreaking ImmuneCODE database to share populationwide immune response to the COVID-19 virus
PR Newswire · 06/11 14:00
UPDATE Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
GlobeNewswire · 06/08 21:03
Goldman Sachs: These 2 Stocks Are Poised to Surge by at Least 30%
TipRanks · 06/07 11:25
Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
GlobeNewswire · 05/27 21:03
Pandemic Damage And The Vaccine Industry
Seeking Alpha - Article · 05/26 10:46
Adaptive Biotechnologies (ADPT) Investor Presentation - Slideshow
Seeking Alpha - Article · 05/13 18:25